Corvus Pharmaceuticals Announces New Preclinical Data Highlighting Potential of Soquelitinib to Treat Systemic Sclerosis | Morningstar

Corvus Pharmaceuticals Announces New Preclinical Data Highlighting Potential of Soquelitinib to Treat Systemic Sclerosis Adds to growing body of evidence supporting the potential of ITK inhibition as a novel therapeutic for the treatment of
Read more...